Clinical Outcomes Archives

Transfusing the right product to the right patient

by jaycornell | May 5, 2025

Dr. Fabrice Cognasse, PhD Auvergne-Rhône-Alpes Regional Blood Center of the French National Blood Establishment INSERM 1059/University of Lyon Saint-Etienne, France

INTERCEPT treated platelets are effective in preventing bleeding

by jaycornell | May 5, 2025

Asst. Prof. Dr. Gerda Leitner Medical University/General Hospital Vienna Vienna, Austria

Clinical performance of INTERCEPT and solvent detergent plasma used with idiopathic thrombotic purpura patients requiring therapeutic plasma exchanges

by jaycornell | May 5, 2025

Dr. Mario Ojeda-Uribe, MD Groupe Hospitalier Region Mulhouse Sud-Alsace (GHRMSA) Hospital E. Muller Mulhouse, France

What does published literature tell us about the clinical efficacy of INTERCEPT treated platelets?

by jaycornell | May 5, 2025

Dr. Joan Cid Vidal Hospital Clínic Barcelona, Spain

Safety surveillance and the introduction of pathogen reduced platelets

by jaycornell | May 5, 2025

Dr. John Pitman, PhD Cerus Corporation Concord, USA